Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.560
+0.140 (4.09%)
At close: Oct 31, 2025, 4:00 PM EDT
3.590
+0.030 (0.84%)
After-hours: Oct 31, 2025, 7:20 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $220.78 million as of October 31, 2025. Its market cap has increased by 12.59% in one year.
Market Cap
220.78M
Enterprise Value
151.30M
1-Year Change
12.59%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $220.78M, a decrease of -57.85%. That is a compound annual growth rate of -19.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 220.78M | 138.00% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |